HemOnc: EPCORE-FL2
Trial ID
06191744
Trial Sponsor
Genmab
HemOnc: EPCORE-FL2 (M22-003)
A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma